SCHEMBL2606142

SCHEMBL2606142

Cc1cccc(N(c2cccc(C)c2)c2cc(N(c3cccc(C)c3)c3cccc(C)c3)cc(C3(c4nc(-c5ccccc5)nc(-c5ccccc5)n4)c4ccccc4-c4ccccc43)c2)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.35
▸ ABCG2 Q9UNQ0 2/20 0.35
▸ ABCB1 P08183 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ NR1I3 Q14994 1/20 0.34
▸ PDK2 Q15119 1/20 0.33
▸ DPP4 P27487 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ TP53 P04637 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ PDE5A O76074 2/20 0.32
▸ KMT2A Q03164 3/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ LMNA P02545 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ ADORA2A P29274 1/20 0.31
▸ ADORA1 P30542 1/20 0.31
▸ RAD52 P43351 1/20 0.30
▸ ESR1 P03372 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2606105 0.83 ESR1 (0.42) MAPTSMN1; SMN2PDK2RAB9AKMT2A
SCHEMBL2606100 0.83 PDE5A (0.30) MAPTSMN1; SMN2PDE5AKMT2AMEN1
SCHEMBL12864440 0.82 ABCG2 (0.31) ABCG2PDE5A
SCHEMBL17899968 0.80 MEN1 (0.38) MAPTABCG2SMN1; SMN2DPP4L3MBTL1
SCHEMBL17893795 0.80 MEN1 (0.41) MAPTSMN1; SMN2L3MBTL1POLBPDE5A
SCHEMBL22473022 0.77 MEN1 (0.36) MAPTABCG2SMN1; SMN2L3MBTL1PDE5A
SCHEMBL17899967 0.76 MAPT (0.41) MAPTSMN1; SMN2PDK2L3MBTL1POLB
SCHEMBL17899903 0.76 MEN1 (0.34) MAPTSMN1; SMN2PDK2L3MBTL1KMT2A
SCHEMBL12864073 0.75 MEN1 (0.42) MAPTSMN1; SMN2PDK2L3MBTL1POLB
SCHEMBL13020933 0.74 ESR1 (0.44) MAPTSMN1; SMN2PDK2L3MBTL1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023117835-A1 ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2023-06-29 — — WO disclosed
US-8361638-B2 Fluorine derivatives for organic electroluminescence devices MERCK PATENT GMBH (DE) 2013-01-29 — — US disclosed
US-8361638-B2 Fluorine derivatives for organic electroluminescence devices MERCK PATENT GMBH (DE) 2013-01-29 — — US disclosed
EP-2260023-B1 FLUORENE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2012-04-25 — — EP disclosed
US-20110037027-A1 FLUORINE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2011-02-17 — — US disclosed
US-20110037027-A1 FLUORINE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2011-02-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110037027-A1 FLUORINE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENCE DEVICES SLCO4C1, CTCF, AFF2 MAPT 302/4885ABCG2 793/4885ABCB1 465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback